OPKO Health, Inc. (OPK) stock
OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.69+0.07 (+4.32%)
Close on Nov 18, 2026Market cap $1.26BP/E –Yield –
OPKO Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
OPKO Health's revenue for the twelve months ending Jun 30, 2026 was $587.90M, down 11.5% year over year. For fiscal 2025 it was $606.88M, down 14.9% from the year before. Over ten years it grew 2.1% a year on average. The highest annual figure on record is $1.77B in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $606.88M | -14.9% |
| FY2024 | Dec 31, 2024 | $713.14M | -17.4% |
| FY2023 | Dec 31, 2023 | $863.50M | -14.0% |
| FY2022 | Dec 31, 2022 | $1.00B | -43.4% |
| FY2021 | Dec 31, 2021 | $1.77B | +23.6% |
| FY2020 | Dec 31, 2020 | $1.44B | +59.1% |
| FY2019 | Dec 31, 2019 | $901.94M | -8.9% |
| FY2018 | Dec 31, 2018 | $990.27M | +2.5% |
| FY2017 | Dec 31, 2017 | $966.01M | -13.6% |
| FY2016 | Dec 31, 2016 | $1.12B | +127.3% |
| FY2015 | Dec 31, 2015 | $491.74M | +439.6% |
| FY2014 | Dec 31, 2014 | $91.13M | -5.6% |
| FY2013 | Dec 31, 2013 | $96.53M | +105.2% |
| FY2012 | Dec 31, 2012 | $47.04M | +68.1% |
| FY2011 | Dec 31, 2011 | $27.98M | -1.8% |
| FY2010 | Dec 31, 2010 | $28.49M | +545.0% |
| FY2009 | Dec 31, 2009 | $4.42M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $163.58M | +4.3% |
| Q1 FY2026 | Mar 31, 2026 | $124.20M | -17.2% |
| Q4 FY2025 | Dec 31, 2025 | $148.45M | -19.2% |
| Q3 FY2025 | Sep 30, 2025 | $151.67M | -12.6% |
| Q2 FY2025 | Jun 30, 2025 | $156.81M | -13.9% |
| Q1 FY2025 | Mar 31, 2025 | $149.95M | -13.7% |
| Q4 FY2024 | Dec 31, 2024 | $183.64M | +1.0% |
| Q3 FY2024 | Sep 30, 2024 | $173.63M | -2.8% |
| Q2 FY2024 | Jun 30, 2024 | $182.19M | -31.4% |
| Q1 FY2024 | Mar 31, 2024 | $173.69M | -26.9% |
| Q4 FY2023 | Dec 31, 2023 | $181.91M | -1.9% |
| Q3 FY2023 | Sep 30, 2023 | $178.60M | -0.6% |
| Q2 FY2023 | Jun 30, 2023 | $265.42M | -14.4% |
| Q1 FY2023 | Mar 31, 2023 | $237.58M | -27.8% |
| Q4 FY2022 | Dec 31, 2022 | $185.34M | -53.8% |
| Q3 FY2022 | Sep 30, 2022 | $179.74M | -53.4% |
| Q2 FY2022 | Jun 30, 2022 | $309.89M | -30.0% |
| Q1 FY2022 | Mar 31, 2022 | $329.22M | -39.6% |
| Q4 FY2021 | Dec 31, 2021 | $401.33M | -18.9% |
| Q3 FY2021 | Sep 30, 2021 | $385.81M | -9.9% |
| Q2 FY2021 | Jun 30, 2021 | $442.41M | +46.9% |
| Q1 FY2021 | Mar 31, 2021 | $545.17M | +157.8% |
| Q4 FY2020 | Dec 31, 2020 | $494.68M | +120.5% |
| Q3 FY2020 | Sep 30, 2020 | $428.06M | +87.1% |
| Q2 FY2020 | Jun 30, 2020 | $301.21M | +33.1% |
| Q1 FY2020 | Mar 31, 2020 | $211.47M | -4.9% |
| Q4 FY2019 | Dec 31, 2019 | $224.34M | +1.1% |
| Q3 FY2019 | Sep 30, 2019 | $228.77M | -8.4% |
| Q2 FY2019 | Jun 30, 2019 | $226.37M | -14.2% |
| Q1 FY2019 | Mar 31, 2019 | $222.45M | -12.7% |
| Q4 FY2018 | Dec 31, 2018 | $221.85M | +37.8% |
| Q3 FY2018 | Sep 30, 2018 | $249.82M | +1.5% |
| Q2 FY2018 | Jun 30, 2018 | $263.69M | -9.9% |
| Q1 FY2018 | Mar 31, 2018 | $254.91M | -4.3% |
| Q4 FY2017 | Dec 31, 2017 | $160.98M | -41.6% |
| Q3 FY2017 | Sep 30, 2017 | $246.04M | -17.4% |
| Q2 FY2017 | Jun 30, 2017 | $292.60M | – |
| Q1 FY2017 | Mar 31, 2017 | $266.38M | – |
| Q4 FY2016 | Dec 31, 2016 | $275.49M | – |
| Q3 FY2016 | Sep 30, 2016 | $298.04M | – |
See a number that looks wrong?